Joint Clinical Assessment from 2025 – opportunity for new medical technologies on Polish and EU markets
There is no denying that the beginning of 2025 promises to be a dynamic year in terms of regulatory changes relevant to the life sciences and healthcare industry, for the European Union as a whole, but also for Poland in particular.